HBIONasdaq United States
Market cap
$29.181 M
$6.47 +4.52%
Close of 7 Aug 2026
Revenue
$86.5M
#2562 by revenue
Earnings
-$56.7M
Loss-making
Shares outstanding
44,719,894
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Harvard Bioscience are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.